Clinical Trials Directory

Trials / Unknown

UnknownNCT02754791

Reducing Blood Culture Contamination:

Reducing Blood Culture Contamination: a Prospective Crossover Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,500 (estimated)
Sponsor
Shaare Zedek Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Bloodstream infections cause significant morbidity and mortality and their prompt identification is an essential part of modern medicine. False positive results in blood cultures are primarily due to contaminants. It has been estimated that up to 50% of positive blood cultures represent contamination. These false positive cultures, at the microbiological laboratory level, require significant additional resources for workup. Additionally, they result in unnecessary antibiotic treatment and hospitalization days, causing needless harm to patients. Various methods have been implemented in order to reduce blood culture contaminants, including modifying the solution used for sterilizing the skin and feedback on contamination rates. However, it has been shown that the bacteria which colonize the human skin are not only on the surface but in fact colonize deeper surfaces as well. The SteriPath device diverts the initial 1-2 ml blood so as to remove any potential skin plug with contaminants. Thus, the principle object of this study is the determination of the rate of contamination of blood culture taken prior to initiating intervention versus the rate of contamination using three interventions: Monthly feedback via departmental report card, a chlorhexidine plus alcohol wipe and the SteriPath device. Secondary objectives will include ease of use of the wipes and the SteriPath device and an estimate of the sensitivity of SteriPath device use to true bacteremia. If the various interventions will be shown to reduce contamination, researchers will also attempt to estimate the financial effects of those reductions, comparing intervention cost to estimated savings related to reduced contamination.

Conditions

Interventions

TypeNameDescription
DEVICESteripathA device that diverts the first 2 ml of blood drawn in order to reduce contamination
DEVICESoluprepWipes containing alcohol (70%) and chlorhexidine (2%) to achieve skin sterilization

Timeline

Start date
2016-05-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2016-04-28
Last updated
2016-05-03

Source: ClinicalTrials.gov record NCT02754791. Inclusion in this directory is not an endorsement.